Novel FGFR4-Targeting Single-Domain Antibodies for Multiple Targeted Therapies against Rhabdomyosarcoma
- DOI
- 10.3390/cancers12113313
- Published
- 2020-11-10
- Container
- Cancers
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/cancers12113313,
title = {Novel FGFR4-Targeting Single-Domain Antibodies for Multiple Targeted Therapies against Rhabdomyosarcoma},
author = {Nagjie Alijaj and Sandrine Moutel and Zelia L. Gouveia and Maxim Gray and Maurizio Roveri and Dzhangar Dzhumashev and Florian Weber and Gianmarco Meier and Paola Luciani and Jochen K. Rössler and Beat W. Schäfer and Franck Perez and Michele Bernasconi},
year = {2020},
journal = {Cancers},
doi = {10.3390/cancers12113313},
url = {https://doi.org/10.3390/cancers12113313}
}RIS
TY - JOUR TI - Novel FGFR4-Targeting Single-Domain Antibodies for Multiple Targeted Therapies against Rhabdomyosarcoma AU - Nagjie Alijaj AU - Sandrine Moutel AU - Zelia L. Gouveia AU - Maxim Gray AU - Maurizio Roveri AU - Dzhangar Dzhumashev AU - Florian Weber AU - Gianmarco Meier AU - Paola Luciani AU - Jochen K. Rössler AU - Beat W. Schäfer AU - Franck Perez AU - Michele Bernasconi PY - 2020 JO - Cancers DO - 10.3390/cancers12113313 UR - https://doi.org/10.3390/cancers12113313 ER -
APA
Alijaj, N., Moutel, S., Gouveia, Z. L., Gray, M., Roveri, M., Dzhumashev, D., Weber, F., Meier, G., Luciani, P., Rössler, J. K., Schäfer, B. W., Perez, F., & Bernasconi, M. (2020). Novel FGFR4-Targeting Single-Domain Antibodies for Multiple Targeted Therapies against Rhabdomyosarcoma. Cancers. https://doi.org/10.3390/cancers12113313
Source records
- crossref · retrieved 2026-09-27T02:19:05.669Z